Educational information, reviewed by Ryan Arvizo, FNP-C. Current as of August 2026.
Ozempic, Wegovy, Mounjaro, Zepbound — the brand names are everywhere, and they make the whole thing sound more complicated than it is. Here’s the simplifying truth: there are really only two medications underneath all four names.
Two medications, four famous names
- Semaglutide is the medication behind Ozempic and Wegovy.
- Tirzepatide is the medication behind Mounjaro and Zepbound.
The brand names differ mainly by what they’re FDA-approved for and how they’re dosed, not by a different active ingredient.
Why the same medication has two names
It comes down to approved use:
- Ozempic (semaglutide) — approved for type 2 diabetes.
- Wegovy (semaglutide) — approved for weight management.
- Mounjaro (tirzepatide) — approved for type 2 diabetes.
- Zepbound (tirzepatide) — approved for weight management.
So “Ozempic vs. Wegovy” isn’t really two medications — it’s one medication (semaglutide) with two brand identities and labeled uses.
Semaglutide vs. tirzepatide: the real distinction
The meaningful difference isn’t between brands — it’s between the two medications:
- Semaglutide activates one hormone pathway (GLP-1).
- Tirzepatide activates two (GLP-1 and GIP).
Both have large, high-quality trial evidence; tirzepatide has generally shown a larger average weight loss, though individual results vary and the best-tolerated option isn’t always the one with the bigger average. (We have a dedicated semaglutide-vs-tirzepatide guide if you want to go deeper.)
The safety point that applies to all of them
No matter the brand, GLP-1 and dual-agonist medications carry an FDA Boxed Warning regarding thyroid C-cell tumors and aren’t appropriate for everyone. A provider screens your personal and family history before prescribing — which is why these are prescribed inside a care relationship, not bought off a menu.
How BioPeakRx fits
At BioPeakRx, these medications are prescribed only after a Provider Evaluation, when clinically appropriate, and prepared through state-licensed U.S. pharmacies. What matters for your results is the medication and the monitoring around it — not the brand on the box.
The bottom line
Four names, two medications. Once you see that semaglutide = Ozempic/Wegovy and tirzepatide = Mounjaro/Zepbound, the whole landscape gets a lot less confusing — and the real conversation (which medication, if any, fits you) is one to have with a provider.
Sources
This information is educational and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved. Treatments require evaluation by a licensed provider.